Faaborg P M, Christensen P, Kvitsau B, Buntzen S, Laurberg S, Krogh K
Department of Surgery P, Aarhus University Hospital, Aarhus, Denmark.
Spinal Cord. 2009 Jul;47(7):545-9. doi: 10.1038/sc.2008.159. Epub 2008 Dec 23.
Long-term follow-up study.
Short-term results find transanal colonic irrigation (TAI) favourable in the treatment of neurogenic bowel dysfunction (NBD). Therefore, long-term results need to be described.
Department of Surgery P, Aarhus University Hospital, Denmark.
Between 1994 and 2007, 211 (115 female) patients with NBD (age: 7-81 years (median 49)) were introduced to TAI. One hundred and seventy-three patients had spinal cord injury and 38 had other neurological disorders. Data were obtained from hospital records and a mailed questionnaire. Treatment was considered successful in patients still using TAI, patients who had used TAI until they died and patients whose symptoms had resolved while using TAI.
Successful outcome was achieved in 98 (46%) patients after a mean follow-up of 19 months (range 1-114 months). A Kaplan-Meier plot showed a dropout of 20% in the first 3 months. After 3 years, the rate of success was 35% and remained almost unchanged afterwards. A regression analysis showed male gender (odds ratio (OR) 2.1), mixed symptoms (OR 2.9) and prolonged colorectal transit time (OR 2.4) to be significantly associated with successful outcome. One non-lethal bowel perforation occurred in approximately 50,000 irrigations (0.002%), whereas minor side effects were observed in 48%.
After a mean follow-up of 19 months, 46% was successfully treated. The rate of success was 35% after 3 years and remained almost unchanged afterwards. TAI is safe and can be introduced to most patients suffering from NBD.
长期随访研究。
短期结果显示经肛门结肠灌洗(TAI)在治疗神经源性肠功能障碍(NBD)方面效果良好。因此,需要描述其长期结果。
丹麦奥胡斯大学医院外科P部。
1994年至2007年间,211例(115例女性)NBD患者(年龄7 - 81岁,中位数49岁)接受了TAI治疗。173例患者有脊髓损伤,38例有其他神经系统疾病。数据来自医院记录和邮寄问卷。仍在使用TAI的患者、使用TAI直至死亡的患者以及在使用TAI期间症状缓解的患者被视为治疗成功。
平均随访19个月(范围1 - 114个月)后,98例(46%)患者治疗成功。Kaplan - Meier曲线显示前3个月有20%的患者退出。3年后,成功率为35%,此后几乎保持不变。回归分析显示男性(优势比(OR)2.1)、混合症状(OR 2.9)和结肠传输时间延长(OR 2.4)与成功结果显著相关。在约50000次灌洗中发生了1例非致命性肠穿孔(0.002%),而48%的患者观察到轻微副作用。
平均随访19个月后,46%的患者治疗成功。3年后成功率为35%,此后几乎保持不变。TAI安全,可应用于大多数NBD患者。